EITMX
Price
$132.41
Change
+$1.83 (+1.40%)
Updated
Jul 31 closing price
Net Assets
3.15B
RGEBX
Price
$80.73
Change
+$0.93 (+1.17%)
Updated
Jul 31 closing price
Net Assets
356.86B
Interact to see
Advertisement

EITMX vs RGEBX

EITMX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
EITMX vs. RGEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EITMX is a Buy and RGEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 357B vs. EITMX (3.15B). EITMX pays higher dividends than RGEBX: EITMX (0.41) vs RGEBX (0.00). EITMX was incepted earlier than RGEBX: EITMX (27 years) vs RGEBX (12 years). RGEBX (1.08) is less costly to investors than EITMX (0.46). RGEBX is a more actively managed with annual turnover of: 32.00 vs. EITMX (14.00). RGEBX has a lower initial minimum investment than EITMX: RGEBX (250) vs EITMX (1000000). EITMX annual gain was more profitable for investors over the last year : 12.69 vs. RGEBX (0.66). EITMX return over 5 years is better than : 64.91 vs. RGEBX (9.78).
EITMXRGEBXEITMX / RGEBX
Total Expense Ratio0.461.0843%
Annual Report Gross Expense Ratio0.461.0843%
Fund Existence27 years12 years-
Gain YTD8.4445.309159%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.15B357B1%
Annual Yield % from dividends0.410.00-
Returns for 1 year12.690.661,920%
Returns for 3 years59.8232.78183%
Returns for 5 years64.919.78664%
Returns for 10 years257.8390.83284%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAE25.82-0.01
-0.04%
CAE Inc
SATA96.90-0.31
-0.32%
Strive Inc
PAX10.82-0.15
-1.37%
Patria Investments Limited
XNET5.34-0.32
-5.65%
Xunlei Limited
KPTI1.92-5.09
-72.61%
Karyopharm Therapeutics Inc.